A Cost-Consequence Analysis of Xpert Xpress CoV-2/Flu/RSV Plus for the Diagnosis of Viral Respiratory Infections from a US Health Plan Perspective

被引:0
|
作者
Davies, S. [1 ]
Boller, E. [2 ]
Beaubrun, A. [3 ]
Miller, C. [4 ]
Jensen, I. [5 ]
机构
[1] Precis HEOR, Bethesda, MD USA
[2] Precis HEOR, New York, NY USA
[3] Cepheid, Sunnyvale, CA USA
[4] Precis Value, Bethesda, MD USA
[5] Precis HEOR, Boston, MA USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
ID039
引用
收藏
页码:S64 / S64
页数:1
相关论文
共 4 条
  • [1] A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses
    Davies, Shawn
    Boller, Emily
    Chase, Jordan
    Beaubrun, Anne
    Miller, Cynthia
    Jensen, Ivar
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 430 - 441
  • [2] Rapid Evaluation of the Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV plus Tests
    Noble, Lara Dominique
    Scott, Lesley Erica
    Munir, Riffat
    Du Plessis, Mignon
    Steegen, Kim
    Hans, Lucia
    Marokane, Puleng
    Da Silva, Pedro
    Stevens, Wendy Susan
    [J]. DIAGNOSTICS, 2023, 13 (01)
  • [3] Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV plus and Alinity m Resp-4-Plex Assay
    Chan, Wai-Sing
    Wong, Kan-Pui
    Yau, Siu-Kei
    Wong, Ching-Yan
    Chan, Tsz-Ching
    Hung, Jeffrey
    Lai, Kristi Tsz-Wan
    Leung, Chin-Pang
    Wang, Candy Ling-Na
    Au, Chun-Hang
    Wan, Thomas Shek-Kong
    Ma, Edmond Shiu-Kwan
    Tang, Bone Siu-Fai
    [J]. DIAGNOSTICS, 2024, 14 (07)
  • [4] Evaluation of the analytical and clinical performance of two RT-PCR based point-of-care tests; Cepheid Xpert ® Xpress CoV-2/Flu/RSV plus and SD BioSensor STANDARD™ M10 Flu/RSV/SARS-CoV-2
    Jensen, Christel Barker
    Schneider, Uffe Vest
    Madsen, Tina Vasehus
    Nielsen, Xiaohui Chen
    German, Chih Man
    Severinsen, Jette Krogh
    Hoegh, Anne Mette
    Botnen, Amanda Bolt
    Trebbien, Ramona
    Lisby, Jan Gorm
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2024, 172